HC Wainwright Issues Pessimistic Forecast for AMLX Earnings
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Free Report) – Equities research analysts at HC Wainwright dropped their FY2025 earnings per share (EPS) estimates for shares of Amylyx Pharmaceuticals in a research note issued on Wednesday, March 5th. HC Wainwright analyst A. Fein now expects that the company will post earnings of ($1.76) per share for the […]
